What is the main business of Bliss Pharma?

The main business activity of Bliss Pharma focuses on manufacture of pharmaceutical preparations.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on March 20, 2023.

Where is the headquarters located?

The headquarters is located at: ul. Aleja T. Kościuszki 101, 90-441 Łódź.

Who is on the management board?

The management board consists of: Jan Osiński (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 6,000 (approx. $1,621).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What revenue was generated?

In 2025, the company's revenue reached USD 1.

No, in 2025 the company reported a net loss of USD 941.

What is the main operating cost?

The largest operating cost category falls under other operating costs. This category amounted to USD 867 in 2025, representing 92% of all operating expenses.

Bliss Pharmasp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2023-03-20

Share capital

6,000.00 PLN

Activity description

Bliss Pharma operates in cannabis, registration and GMP audits. The company is based in Lodz, Poland.

Registered address

ul. Aleja T. Kościuszki 101, 90-441 Łódź, Poland

Website

bliss-pharma.com

Electronic delivery address

AE:PL-66751-14172-AIWGT-20

Financials

Revenue history

Filing timeliness

2 of 3 financial statements were filed late (the longest delay 29 days for 2023), 1 not filed.

202517/07/2026
2024not filed
202313/08/2024

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 0.69MedianUSD 917.74kAverageUSD 25.73m

Net profit

This companyUSD -940.51MedianUSD 14.44kAverageUSD 2.75m

Operating costs

This companyUSD 941.01MedianUSD 860.03kAverageUSD 21.34m

Assets

This companyUSD 4.75kMedianUSD 883.09kAverageUSD 31.39m

Industry

Authorized Representatives

Jan Osiński – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Maciej Krzysztof Kociołekage 43	20	$540.25	33.3333%
Jan Osińskiage 43	10	$270.12	16.6667%
Agnieszka Pawlataage 40	20	$540.25	33.3333%
Teresa Ewa Witos Osińskaage 44	10	$270.12	16.6667%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2024-07-13.

PKO Bank Polski
52 1020 3408 0000 4102 0567 2441

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Aflofarm Farmacja Polskasp. z o.o.	$302,019,142.07	aflofarm.pl
PolfarmexS.A.	$73,543,379.32	polfarmex.pl
Toruńskie Zakłady Materiałów Opatrunkowych Tkalnie ZelówS.A.	$11,288,459.46	kontakt.tkalniezelow.pl
Biomarsp. z o.o.	$909,113.28	biomar.pl
BIO Animalisp. z o.o.	$49,176.96	proanimali.com
Ampliconsp. z o.o.	$48,330.99	amplicon.pl
Xenira Pharmaceuticalssp. z o.o.	$26,670.82	xenirapharma.com
Sanford Biotechsp. z o.o.	$2,586.64	sanfordbiotech.com
Cefeasp. z o.o.	$294.66	cefea.pl
Auxilius PharmaS.A.	$0.83	auxiliuspharma.com